BlackRock Group’s Pacira BioSciences PCRX Stock Holding History

BlackRock Group’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.83M	Sell	56,709 -53,507	-49%	-$1.79M	﹤0.01%	1826
2016 Q3	$3.77M	Buy	110,216 +87,372	+382%	+$3.42M	﹤0.01%	1246
2016 Q2	$771K	Sell	22,844 -210	-0.9%	-$10.3K	﹤0.01%	2084
2016 Q1	$1.22M	Buy	23,054 +3,472	+18%	+$203K	﹤0.01%	1834
2015 Q4	$1.5M	Buy	19,582 +586	+3%	+$33.2K	﹤0.01%	1645
2015 Q3	$780K	Buy	18,996 +5,003	+36%	+$306K	﹤0.01%	2018
2015 Q2	$990K	Sell	13,993 -571	-4%	-$45K	﹤0.01%	1966
2015 Q1	$1.29M	Buy	14,564 +5,297	+57%	+$537K	﹤0.01%	1727
2014 Q4	$821K	Sell	9,267 -27,440	-75%	-$2.6M	﹤0.01%	2003
2014 Q3	$3.56M	Buy	36,707 +30,576	+499%	+$2.97M	﹤0.01%	1202
2014 Q2	$564K	Sell	6,131 -10,893	-64%	-$829K	﹤0.01%	2156
2014 Q1	$1.19M	Buy	17,024 +6,230	+58%	+$424K	﹤0.01%	1906
2013 Q4	$620K	Buy	10,794 +4,625	+75%	+$243K	﹤0.01%	2152
2013 Q3	$297K	Buy	6,169 +4,365	+242%	+$159K	﹤0.01%	2382
2013 Q2	$52K	Buy	+1,804	New	+$52.2K	﹤0.01%	2434

Other funds holding PCRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return